Filing Flows › Invivyd (IVVD) › Recalls, complaints & regulation
Invivyd (IVVD): clinical trials
Invivyd (IVVD) beyond its filings: 3 active clinical trials.
Invivyd's latest quarter
Invivyd, Q2 2026: revenue $14.3M (+21% year over year), operating margin -320.8%, net loss $44.4M, operating cash flow −$43.0M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Invivyd have?
3 active studies on ClinicalTrials.gov, 1 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.